ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Anesthesiology

Top Anesthesiology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JORDAN FERSEL M.D.

Anesthesiology

1,939

$265K

134
22 are 65+

87%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $127

PETER CORDA DO

Anesthesiology

1,400

$258K

141
73 are 65+

48%
patients receiving schedule two controlled substances

Avg: 67%

26%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$184
Average prescription price

Avg: $127

STEVEN RESSLER MD

Anesthesiology

1,286

$181K

218
90 are 65+

72%
patients receiving schedule two controlled substances

Avg: 67%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$141
Average prescription price

Avg: $127

RICHARD WINNE MD

Anesthesiology

1,278

$162K

189
137 are 65+

43%
patients receiving schedule two controlled substances

Avg: 67%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $127

JOSE ISIDRO MD

Anesthesiology

1,189

$162K

100
38 are 65+

84%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $127

GARY BUCK MD

Anesthesiology

1,135

$117K

297
86 are 65+

75%
patients receiving schedule two controlled substances

Avg: 67%

7%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $127

KIERAN SLEVIN MD

Anesthesiology

995

$108K

191
94 are 65+

50%
patients receiving schedule two controlled substances

Avg: 67%

16%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $127

ARUN KANDRA M.D.

Anesthesiology

972

$85.7K

101
23 are 65+

76%
patients receiving schedule two controlled substances

Avg: 67%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $127

DAVID CONYACK D.O.

Anesthesiology

956

$123K

141
94 are 65+

49%
patients receiving schedule two controlled substances

Avg: 67%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $127

YOUNG J. LEE M.D.

Anesthesiology

892

$70.9K

253
86 are 65+

71%
patients receiving schedule two controlled substances

Avg: 67%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $127

VINCENT PADULA DO

Anesthesiology

884

$244K

173
75 are 65+

79%
patients receiving schedule two controlled substances

Avg: 67%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$276
Average prescription price

Avg: $127

JEFFREY POLCER DO

Anesthesiology

840

$66.3K

157
65 are 65+

48%
patients receiving schedule two controlled substances

Avg: 67%

22%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $127

ASHRAF SAKR MD

Anesthesiology

837

$47.6K

84
28 are 65+

68%
patients receiving schedule two controlled substances

Avg: 67%

27%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $127

EMANUEL LAMPROU MD

Anesthesiology

818

$170K

63
0 are 65+

90%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $127

CHINWEIKE IZEOGU MD

Anesthesiology

668

$50.3K

143
36 are 65+

87%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $127

WILLIAM GRUBB MD

Anesthesiology

659

$65.6K

54
19 are 65+

61%
patients receiving schedule two controlled substances

Avg: 67%

20%
patients receiving schedule three controlled substances

Avg: 11%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $127

SAMUEL CARUTHERS M.D.

Anesthesiology

605

$58.1K

92
18 are 65+

77%
patients receiving schedule two controlled substances

Avg: 67%

25%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$96
Average prescription price

Avg: $127

NINGNING HE MD

Anesthesiology

494

$61K

59
41 are 65+

51%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$123
Average prescription price

Avg: $127

JAGJEET SINGH M.D.

Anesthesiology

492

$23.7K

122
85 are 65+

38%
patients receiving schedule two controlled substances

Avg: 67%

22%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $127

YOORI YIM M.D.

Anesthesiology

488

$78.9K

37
17 are 65+

68%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $127

MALINI RAO MD

Anesthesiology

480

$80.9K

78
12 are 65+

83%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$169
Average prescription price

Avg: $127

CHERRY HILL PAIN MANAGEMENT & WELLNESS CENTER, LLC

Anesthesiology

472

$140K

55
0 are 65+

93%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$298
Average prescription price

Avg: $127

PRAMILA BYAHATTI MD

Anesthesiology

470

$66K

26
0 are 65+

92%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$140
Average prescription price

Avg: $127

BAHER YANNI M.D.

Anesthesiology

458

$56.9K

103
57 are 65+

52%
patients receiving schedule two controlled substances

Avg: 67%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $127

WALTER LAPICKI D.O.

Anesthesiology

440

$66K

60
27 are 65+

80%
patients receiving schedule two controlled substances

Avg: 67%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 24%

$150
Average prescription price

Avg: $127

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank